Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Filings indexed 601 across all filing types
Latest filing 2026-04-04 Governance Information
Country IT Italy
Listing XMIL PHN

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
Report on Corporate Governance and Ownership Structure of Pharmanutra S.p.A,
Governance Information Classification · 1% confidence The document is titled “Report on Corporate Governance and Ownership Structure of Pharmanutra S.p.A.” prepared pursuant to art. 123-bis of Legislative Decree 58/1998. It exclusively covers governance topics: share capital structure, board composition, committees, internal control, and related governance practices. It contains no financial statements or earnings data, nor is it a brief announcement or proxy material. This aligns with the definition of a standalone Governance Information report (Code: CGR).
2026-04-04 English
Relazione sul Governo Societario e gli Assetti Proprietari di Pharmanutra S.p.A.
Governance Information Classification · 1% confidence The document is titled “Relazione sul governo societario e gli assetti proprietari” and is prepared under art. 123-bis of the Italian TUF, covering detailed corporate governance structure, board composition, ownership information, and internal committees. It is not an announcement or summary but the full governance report itself, matching the definition of Governance Information (CGR).
2026-04-03 Italian
CS disponibilità documenti per Assemblea | PR availability of documentation for Shareholder's Meeting
Report Publication Announcement Classification · 1% confidence The document is a brief regulatory communication notifying the public that the Report on Corporate Governance and Ownership Structure has been filed and is available for the upcoming Shareholders’ Meeting. It does not contain the full report itself, but simply announces its availability at the registered office, on the website, and via the authorized storage mechanism. This fits the definition of a Report Publication Announcement (RPA).
2026-04-03 Italian
PHARMANUTRA - PHN - ANNUAL FINANCIAL REPORT 2025
Annual Report Classification · 1% confidence The document is a comprehensive 'Annual Financial Report' for PharmaNutra S.p.A. for the fiscal year ending 31 December 2025. It contains a detailed management report, consolidated financial statements (balance sheet, income statement, cash flow), explanatory notes, and an independent auditor's report. It is clearly the full annual report rather than an announcement or a summary, as it exceeds the length requirements and provides full financial disclosures. FY 2025
2026-03-27 English
PHARMANUTRA - PHN - RELAZIONE FINANZIARIA ANNUALE 2025
Annual Report Classification · 1% confidence The document is titled 'RELAZIONE FINANZIARIA ANNUALE' (Annual Financial Report) for the period ending December 31, 2025. It contains comprehensive financial statements, including the Consolidated Balance Sheet, Income Statement, Cash Flow Statement, and detailed explanatory notes (Note Illustrative), as well as the Management Report (Relazione sulla Gestione) and the Audit Report (Relazione Società Revisione). Given the document's length, structure, and inclusion of full financial statements, it is classified as an Annual Report (10-K). FY 2025
2026-03-27 Italian
PHARMANUTRA - PHN - DEPOSITO DOCUMENTAZIONE PER ASSEMBLEA DEGLI AZIONISTI
Report Publication Announcement Classification · 1% confidence The document is a brief announcement stating that the Annual Financial Report (including draft financial statements, consolidated statements, reports on operations, and auditor certifications) has been deposited and is available for the upcoming Shareholders’ Meeting. It does not contain the actual financial statements but merely notifies stakeholders where and when to access the materials. This matches the definition of a Report Publication Announcement (RPA).
2026-03-27 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.